NeuroRx is a clinical stage, small molecule pharmaceutical company developing novel therapeutics for mood disorders when they are associated with Acute Suicidal Ideation & Behavior (ASIB), such as Bipolar Depression, PTSD.
Our first treatment regimen is NRX-100/NRX-101, it is being developed for Bipolar Depression in patients with Acute Suicidal Ideation & Behavior
The NeuroRx team reaches beyond boundaries, thinks beyond standards and explores beyond borders. We have the courage to try what others have not yet tried.
We are a dynamic start-up, committed to our mission of bringing life saving treatments to patients. Most of our colleagues operate out of our Radnor-based clinical office, near Philadelphia.
However, in the development of pharmaceutical products there are frequent changes. Hence, if you believe you can contribute to our development of NRX-100/NRX-101, we would like to hear from you at email@example.com.